Covid Lists

RU2297846C2 - Method for treatment of focal and infiltrative pulmonary tuberculosis - Google Patents

Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis

Patient infected with COVID-19 finally cured after 411 days

Does Tenofovir Disoproxil Fumarate Mitigate COVID-19 Outcomes in Men with HIV?

Tenofovir and COVID: The Jury Is Still Out

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

‘Old style’ tenofovir really may protect against COVID, large US study finds

Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV

Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases

Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study

Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients - BMC Infectious Diseases

Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities

Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study - BMC Infectious Diseases

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study

SARS-Cov-2 Associated Neurocognitive Decline (SAND) Scan

Murphy's Medicine Podcast: Episode One. SARS CoV2 Associated Neurocognitive Decline

Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment

Dose matters: HIV drug could prevent coronaviruses, study finds

Research shows how HIV drug could stop many coronavirus diseases

Common HIV medication associated with improved COVID-19 outcomes

Myocarditis complications more common after COVID infection than vaccination, 18-month data suggest | CIDRAP

COVID's Spike Protein Enhances Ability to Infect Brain - Neuroscience News

New vector vaccine against COVID-19 provides long-term protection

Long COVID Looks Different in Kids

Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed

Characterizing Long COVID in Children and Adolescents